October 3, 2011
Takeda Pharmaceutical announced on October 1 that it had completed its acquisition of Nycomed (Switzerland) for €9.6 billion (about ¥1.1 trillion, currency rate from the time of Takeda’s acquisition plan announcement.), making Nycomed its wholly owned subsidiary. The acquisition of...read more